New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.

Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.

Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...

Telix Pharmaceuticals Limited today announces that the United Kingdom Medicines and Healthcare Products Regulatory Agency has ...

Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a global ...

To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

The World Health Organization released new findings on Friday about an "alarming" lack of awareness about alcohol's link to ...

A new survey has revealed the huge scale and mindboggling complexity of the task facing pharma in keeping medicines moving around Europe after Brexit. No-one knows if or when the EU27 and the UK ...

Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.